Iran, Islamic Republic of vs Papua New Guinea: Congenital Rubella Syndrome - number of reported cases
Iran, Islamic Republic of
0
in 2025
Papua New Guinea
0
in 2025
Iran, Islamic Republic of rank
16th
Papua New Guinea rank
16th
Congenital Rubella Syndrome - number of reported cases over time
- Iran, Islamic Republic of
- Papua New Guinea
How they compare
Iran, Islamic Republic of currently reports 0 against 0 in Papua New Guinea, a difference of 0.
The two have swapped places 2 times across 12 shared years of data; in 2014 it was Papua New Guinea ahead.
Iran, Islamic Republic of ranks 16th and Papua New Guinea ranks 16th of 187 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3333 | 0.1667 | 0.1667 | Iran, Islamic Republic of |
| 2020s | 0.3333 | 0.3333 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher congenital rubella syndrome - number of reported cases, Iran, Islamic Republic of or Papua New Guinea?
- Iran, Islamic Republic of, at 0 against 0 in Papua New Guinea as of 2025.
- What is the difference in congenital rubella syndrome - number of reported cases between Iran, Islamic Republic of and Papua New Guinea?
- 0, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Papua New Guinea?
- 12 years are reported by both, from 2014 to 2025.
- How do Iran, Islamic Republic of and Papua New Guinea rank globally for congenital rubella syndrome - number of reported cases?
- Iran, Islamic Republic of ranks 16th and Papua New Guinea ranks 16th of 187 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Congenital Rubella Syndrome - number of reported cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.